207 related articles for article (PubMed ID: 9920179)
1. Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
Mayorga AJ; Cousins MS; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Eur J Pharmacol; 1999 Jan; 364(1):7-11. PubMed ID: 9920179
[TBL] [Abstract][Full Text] [Related]
2. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
3. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.
Salamone JD; Correa M; Carlson BB; Wisniecki A; Mayorga AJ; Nisenbaum E; Nisenbaum L; Felder C
Life Sci; 2001 Apr; 68(22-23):2579-84. PubMed ID: 11392629
[TBL] [Abstract][Full Text] [Related]
4. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Collins-Praino LE; Podurgiel SJ; Kovner R; Randall PA; Salamone JD
Behav Brain Res; 2012 Sep; 234(1):129-35. PubMed ID: 22728308
[TBL] [Abstract][Full Text] [Related]
5. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Collins LE; Galtieri DJ; Brennum LT; Sager TN; Hockemeyer J; Müller CE; Hinman JR; Chrobak JJ; Salamone JD
Pharmacol Biochem Behav; 2010 Feb; 94(4):561-9. PubMed ID: 19958787
[TBL] [Abstract][Full Text] [Related]
6. Activation of muscarinic M3-like receptors and beta-adrenoceptors, but not M2-like muscarinic receptors or alpha-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro.
Niittykoski M; Ruotsalainen S; Haapalinna A; Larson J; Sirviö J
Neuroscience; 1999 Apr; 90(1):95-105. PubMed ID: 10188937
[TBL] [Abstract][Full Text] [Related]
7. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects.
Mayorga AJ; Carriero DL; Cousins MS; Gianutsos G; Salamone JD
Pharmacol Biochem Behav; 1997 Feb; 56(2):273-9. PubMed ID: 9050085
[TBL] [Abstract][Full Text] [Related]
8. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
Joseph L; Thomsen M
Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
[TBL] [Abstract][Full Text] [Related]
9. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
[TBL] [Abstract][Full Text] [Related]
10. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
11. Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions.
Finn M; Jassen A; Baskin P; Salamone JD
Pharmacol Biochem Behav; 1997; 57(1-2):243-9. PubMed ID: 9164578
[TBL] [Abstract][Full Text] [Related]
12. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
Purkerson SL; Potter LT
J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
[TBL] [Abstract][Full Text] [Related]
13. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
[TBL] [Abstract][Full Text] [Related]
14. Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.
Garcia N; Santafé MM; Salon I; Lanuza MA; Tomàs J
Histol Histopathol; 2005 Jul; 20(3):733-43. PubMed ID: 15944922
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice.
Maslanski JA; Powelt R; Deirmengiant C; Patelt J
Neurosci Lett; 1994 Feb; 168(1-2):225-8. PubMed ID: 8028781
[TBL] [Abstract][Full Text] [Related]
16. On muscarinic control of neurogenic mucus secretion in ferret trachea.
Ramnarine SI; Haddad EB; Khawaja AM; Mak JC; Rogers DF
J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):577-86. PubMed ID: 8842014
[TBL] [Abstract][Full Text] [Related]
17. Effects of striatal injections of 8-bromo-cyclic-AMP on pilocarpine-induced tremulous jaw movements in rats.
Mayorga AJ; Gianutsos G; Salamone JD
Brain Res; 1999 May; 829(1-2):180-4. PubMed ID: 10350545
[TBL] [Abstract][Full Text] [Related]
18. Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.
Carlson BB; Trevitt JT; Salamone JD
Pharmacol Biochem Behav; 2000 Apr; 65(4):683-9. PubMed ID: 10764923
[TBL] [Abstract][Full Text] [Related]
19. On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder.
Giglio D; Delbro DS; Tobin G
Eur J Pharmacol; 2001 Oct; 428(3):357-64. PubMed ID: 11689195
[TBL] [Abstract][Full Text] [Related]
20. Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.
Aura J; Sirviö J; Riekkinen P
Eur J Pharmacol; 1997 Aug; 333(2-3):129-34. PubMed ID: 9314025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
